Lloyd Price

SEPTEMBER 2, 2023

Growth of the life sciences sector: The life sciences sector is expected to continue to grow in 2023, driven by the development of new drugs and therapies, as well as the increasing demand for personalized medicine. The increased focus on digital health in the European HealthTech M&A market is a positive development.

Life Science 64

Life Science Digital Health EHR BioTech 64

Healthcare IT Today

JANUARY 8, 2024

Health Economics Outcomes Research (HEOR) will become more common in decentralized clinical trials (DCTs). This year we saw the maturation of Claims and Health Information Exchanges, which enable a cost-effective and straightforward process for researchers to gain access to identified patients’ data.

Health IT 81

Health IT Drug Development Pharmaceuticals BioTech 81

Health Populi

APRIL 24, 2019

I analyzed those general results with health/care implications here in Health Populi. In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g., over-the-counter medicines); and, health insurance.

BioTech 205

BioTech Pharmaceuticals Life Science Health Information 205

Health Populi

MAY 30, 2018

The poll results are published in Public Perspectives on Personalized Medicine , with the top-line finding that life science industry innovators must better educate and inform consumers on the opportunities and benefits of personalized medicine. This picture of U.S. Note that autonomy and privacy rank with the most mentions.

Life Science 174

Life Science Health Information HIPAA Health Data 174